Apollomics, Inc. (APLM)
NASDAQ: APLM · Real-Time Price · USD
17.48
-0.74 (-4.06%)
Jul 29, 2026, 4:00 PM EDT - Market closed
Apollomics Market Cap
Apollomics has a market cap or net worth of $38.39 million as of July 29, 2026. Its market cap has increased by 446.18% in one year.
Market Cap
38.39M
Enterprise Value
35.75M
1-Year Change
446.18%
Ranking
Category
Stock Price
$17.48
ChartMarket Cap Chart
Since November 26, 2021, Apollomics's market cap has decreased from $129.59M to $38.39M, a decrease of -70.38%. That is a compound annual growth rate of -22.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 38.39M | -4.33% |
| Dec 31, 2025 | 40.12M | 273.20% |
| Dec 31, 2024 | 10.75M | -87.56% |
| Dec 29, 2023 | 86.40M | -37.89% |
| Dec 30, 2022 | 139.11M | 7.02% |
| Dec 30, 2021 | 129.98M | 0.30% |
| Nov 26, 2021 | 129.59M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RenovoRx | 43.53M |
| Filana Therapeutics | 43.50M |
| Dyadic International | 41.18M |
| Hyperion DeFi | 38.80M |
| PDS Biotechnology | 38.66M |
| eXoZymes | 38.58M |
| Genenta Science | 37.51M |
| Grace Therapeutics | 37.43M |